title: Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas.
abstract: Abnormality of the cyclin D1/cdk4/p16INK4a/pRb pathway during tumorigenesis has recently been reported. Hepatoblastoma is a rare malignant liver tumor of childhood, but underlying abnormalities of cell-cycle regulating protein remain to be elucidated. The expression of cyclin D1, cdk4, p16 and retinoblastoma gene product (pRb) was studied by immunohistochemistry in 17 paraffin-embedded tissues consisting of both tumor and corresponding non-neoplastic tissues. Tumor tissues showed overexpression of cyclin D1 (13/17, 76%) and cdk4 (15/17, 88%). Eleven cases showed co-overexpression of both cyclin D1 and cdk4. No abnormal p16 or pRb expression was noted. In the group with a high score (+4) for cyclin D1 expression, a positive correlation with tumor recurrence was noted (P = 0.043). These data suggest that overexpressed cyclin D1 and cdk4 protein might play an important role in the tumorigenesis of hepatoblastoma and that in the group with high cyclin D1 expression, tumor recurrence may be more frequent.
authors.affiliation: Department of Pathology, Seoul National University College of Medicine, South Korea.
authors.forename: H
authors.initials: H
authors.lastname: Kim
authors.forename: E K
authors.initials: EK
authors.lastname: Ham
authors.forename: Y I
authors.initials: YI
authors.lastname: Kim
authors.forename: J G
authors.initials: JG
authors.lastname: Chi
authors.forename: H S
authors.initials: HS
authors.lastname: Lee
authors.forename: S H
authors.initials: SH
authors.lastname: Park
authors.forename: Y M
authors.initials: YM
authors.lastname: Jung
authors.forename: N K
authors.initials: NK
authors.lastname: Myung
authors.forename: M J
authors.initials: MJ
authors.lastname: Lee
authors.forename: J J
authors.initials: JJ
authors.lastname: Jang
mesh_terms: D000293:Adolescent; D002471:Cell Transformation, Neoplastic; D002648:Child; D002675:Child, Preschool; D019938:Cyclin D1 / Q000378:metabolism*; D051358:Cyclin-Dependent Kinase 4; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000378:metabolism; D018844:Cyclin-Dependent Kinases / Q000378:metabolism*; D005260:Female; D018197:Hepatoblastoma / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D008113:Liver Neoplasms / Q000378:metabolism*; D008297:Male; D011518:Proto-Oncogene Proteins; D016160:Retinoblastoma Protein / Q000378:metabolism
chemical_list: D019941:Cyclin-Dependent Kinase Inhibitor p16; D011518:Proto-Oncogene Proteins; D016160:Retinoblastoma Protein; D019938:Cyclin D1; C495900:CDK4 protein, human; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases